Back to results
US 9,539,204 B2Granted
Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsKazutaka Kido, Takashi Nagano
Life of this patent
Estimating the term…
Abstract
The objective of the present invention is to provide a new medicinal use of clarithromycin. The present invention is a therapeutic agent or a preventive agent for meibomian gland dysfunction or meibomian gland blockage and comprises clarithromycin as an active ingredient. The dosage form is preferably an eye drop or eye ointment.
Claims4
A method of treating meibomian gland concretion, the method comprising administering an effective amount of clarithromycin to a subject in need thereof.
Dependencies are inferred from the claim text.